Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinoma

Clinical Cancer Research

Volumn 14, Issue 12, 2008, Pages 3768-3776

  Tada, Motohisa ^a,b   Kanai, Fumihiko ^a   Tanaka, Yasuo ^a   Tateishi, Keisuke ^a   Ohta, Miki ^a   Asaoka, Yoshinari ^a   Seto, Motoko ^a   Muroyama, Ryosuke ^a   Fukai, Kenichi ^b   Lmazeki, Fumio ^b   Kawabe, Takao ^a   Yokosuka, Osamu ^b   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BISULFITE; HEDGEHOG INTERACTING PROTEIN; REGULATOR PROTEIN; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; 5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CARRIER PROTEIN; CYCLOPAMINE; DRUG DERIVATIVE; HHIP PROTEIN, HUMAN; MEMBRANE PROTEIN; VERATRUM ALKALOID;

ADULT; AGED; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE OVEREXPRESSION; GENETIC MANIPULATION; GENETIC TRANSCRIPTION; HEPATOMA CELL; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; CELL PROLIFERATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC EPISTASIS; GENETICS; HEPATOBLASTOMA; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

AGED; AZACITIDINE; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DOWN-REGULATION; EPISTASIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; VERATRUM ALKALOIDS;

EID: 52449129646     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1181     Document Type: Article

References (49)

1. Harris CC. Hepatocellular carcinogenesis: recent advances and speculations. Cancer Cell 1990:2: 146-8.
2. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;15:948-63.
3. Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 2003;3:903-11.
4. Evangelista M,Tian H, de Sauvage FJ.The hedgehog signaling pathway in cancer. Clin Cancer Res 2006; 12:5924-8.
5. Johnson RL, Rothman AL, Xie J, et al. Human homo-log of patched, a candidate gene for the basal cell nevus syndrome. Science 1996;272:1668-71.
6. Hahn H,Wicking C, Zaphiropoulous PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996; 85:841 -51.
7. Xie J, Murone M, Luoh SM, et al. Activating Smooth-ened mutations in sporadic basal-cell carcinoma. Nature 1998;391:90-2.
8. Reifenberger J, Wolter M, Weber RG, et al. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of
9. the central nervous system. Cancer Res 1998:58: 1798-803.
10. Raffel C, Jenkins RB, Frederick L, et al. Sporadic me-dulloblastomas contain PTCH mutations. Cancer Res 1997;57:842-5.
11. Ohta M,Tateishi K, Kanai F, et al. p53-Independent negative regulation of p21/cyclin-dependent kinase- interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells. Cancer Res 2005;65:10822-9.
12. Berman DM, Karhadkar SS, Maitra A, et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003; 425:846-51.
13. Thayer SP, di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003:425:851 -6.
14. Karhadkar SS, Bova GS, Abdallah N, et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004;431:707-12.
15. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003;422:313-7.
16. Patil MA, Zhang J, Ho C, Cheung ST, Fan ST, Chen X. Hedgehog signaling in human hepatocellular carcinoma. Cancer Biol Ther 2006;5:111 -7.
17. Sicklick JK, Li YX, Jayaraman A, et al. Dysregulation of the Hedgehog pathway in human hepatocarcino- genesis. Carcinogenesis 2006;27:748-57.
18. Huang S, He J, Zhang X, et al. Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis 2006;27:1334-40.
19. Chuang PT, KawcakT, McMahon AP. Feedback control of mammalian Hedgehog signaling by the Hedgehog-binding protein, Hip1, modulates Fgf signaling during branching morphogenesis of the lung. Genes Dev 2003;17:342-7.
20. Olsen CL, Hsu PP, Glienke J, Rubanyi GM, Brooks AR. Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angio-genesis and in several human tumors. BMC Cancer 2004;4:43.
21. Bak M, Hansen C, Friis Henriksen K, Tommerup N. The human hedgehog-interacting protein gene: structure and chromosome mapping to 4q31.21->q31.3. Cytogenet Cell Genet 2001;92:300-3.
22. Chuang PT, McMahon AP. Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature1999;397:617-21.
23. Sasaki H, Hui C, Nakafuku M, Kondoh H. A binding site for Gli proteins is essential for HNF-3β floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development 1997;124:1313-22.
24. Kamachi Y, Kondoh H. Overlapping positive and negative regulatory elements determine lens-specific activity of the δ1-crystallin enhancer. Mol Cell Biol 1993;13:5206-15.
25. Marigo V, Tabin C J. Regulation of patched by sonic hedgehog in the developing neural tube. Proc Natl Acad Sci USA1996;93:9346-51.
26. Lee J, Piatt KA, Censullo P, Ruiz i Altaba A. Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. Development 1997;124: 2537 - 52.
27. Bigelow RL, Chari NS, Unden AB, et al. Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J Biol Chem 2004;279:1197-205.
28. Yoon JW, Kita Y, Frank DJ, et al. Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J Biol Chem 2002;277:5548-55.
29. Eads CA, Danenberg KD, Kawakami K, et al. Methy-Light: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:E32.
30. Eads CA, Lord RV, Kurumboor SK, et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 2000;60:5021-6.
31. Luo L, Shen GQ, Stiffler KA, Wang QK, PretlowTG, Pretlow TP. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer. Carcinogenesis 2006;27:1153-9.
32. Lin JK, Chang SC, Yang YC, Li AF. Loss of heterozygosity and DNA aneuploidy in colorectal adenocarcinoma. Ann Surg Oncol 2003;10:1086-94.
33. Martin ST, Sato N, Dhara S, et al. Aberrant methyl-ation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms. Cancer Biol Ther 2005;4:728-33.
34. Deutsch G, Jung J, Zheng M, Lora J, Zaret KS A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 2001;128:871 -81.
35. Tada M, Omata M, Ohto M. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res 1990;50:1121 -4.
36. Taipale J, Chen JK, Cooper MK, et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 2000;406: 1005-9.
37. Herman JG. Hypermethylation of tumor suppressor genes in cancer. Semin Cancer Biol 1999;9:359-67.
38. Baylin SB, Herman JG, Graff JR,Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998;72:141 -96.
39. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet1999;21:163-7.
40. Kanai Y, Ushijima S, Hui AM, et al. The E-cad-herin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 1997;71:355-9.
41. Liew CT, Li HM, Lo KW, et al. High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene1999;18:789-95.
42. Yoshikawa H, Matsubara K, Qian GS, et al SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity Nat Genet 2001;28:29-35.
43. Iwata N. Yamamoto H, Sasaki S. et al. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3σ gene in human hepatocellular carcinoma. Oncogene 2000;19:5298-302
44. Zhong S, Tang MW,Yeo W, Liu C, Lo YM, Johnson PJ. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Clin Cancer Res 2002;8:1087-92
45. Taniguchi H, Yamamoto H, Akutsu N, et al. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. J Pathol 2007;213:131 - 9
46. NannyaY, Sanada M, Nakazaki K, et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 2005;65:6071 -9
47. Zimonjic DB, Keck CL, Thorgeirsson SS, Popescu NC. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization Hepatology 1999;29: 1208-14.
48. Guan XY, Fang Y, Sham JS, et al. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 2000;29:110-6.
49. Payne SR, Kemp CJ. Tumor suppressor genetics. Carcinogenesis 2005;26:2031 - 45